blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2042188

EP2042188 - PHARMACEUTICAL COMPOSITION FOR TREATING OR PREVENTING HCV INFECTION [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  12.10.2012
Database last updated on 05.10.2024
Most recent event   Tooltip12.10.2012Application deemed to be withdrawnpublished on 14.11.2012  [2012/46]
Applicant(s)For all designated states
Tokyo Metropolitan Institute of Medical Science
1-6, Kamikitazawa 2-chome
Setagaya-ku
Tokyo 156-8506 / JP
For all designated states
CHUGAI SEIYAKU KABUSHIKI KAISHA
5-1, Ukima 5-chome, Kita-ku
Tokyo, 115-8543 / JP
[2012/01]
Former [2009/14]For all designated states
Tokyo Metropolitan Organization for Medical Research
8-1, Nishishinjuku 2-chome Shinjuku-ku
Tokyo 163-8001 / JP
For all designated states
CHUGAI SEIYAKU KABUSHIKI KAISHA
5-1, Ukima 5-chome, Kita-ku
Tokyo, 115-8543 / JP
Inventor(s)01 / KOHARA, Michinori
3-15-3-408, Tabata Kita-ku
Tokyo 114-0014 / JP
02 / UMEHARA, Takuya
2-3-15-203, Tabata Kita-ku
Tokyo 114-0014 / JP
03 / SUDO, Masayuki
CHUGAI SEIYAKU KABUSHIKI KAISHA 200, Kajiwara Kamakura-shi
Kanagawa 247-8530 / JP
 [2009/14]
Representative(s)Vossius & Partner Patentanwälte Rechtsanwälte mbB
Siebertstrasse 3
81675 München / DE
[N/P]
Former [2009/35]Vossius & Partner
Siebertstrasse 4
81675 München / DE
Former [2009/14]Vossius & Partner
Siebertstrasse 4
81675 München / DE
Application number, filing date07743451.216.05.2007
[2009/14]
WO2007JP60016
Priority number, dateJP2006013699216.05.2006         Original published format: JP 2006136992
[2009/14]
Filing languageJA
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2007132882
Date:22.11.2007
Language:JA
[2007/47]
Type: A1 Application with search report 
No.:EP2042188
Date:01.04.2009
Language:EN
[2009/14]
Search report(s)International search report - published on:JP22.11.2007
(Supplementary) European search report - dispatched on:EP17.10.2011
ClassificationIPC:A61K38/21, A61K45/00, A61P1/16, A61P31/12, A61P35/00
[2009/14]
CPC:
A61K38/21 (EP,KR); A61K31/197 (KR); A61K45/06 (EP);
A61P1/16 (EP); A61P31/12 (EP); A61P31/14 (EP);
A61P35/00 (EP) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MT,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2009/14]
TitleGerman:PHARMAZEUTISCHE ZUSAMMENSETZUNG ZUR BEHANDLUNG ODER PRÄVENTION VON HCV-INFEKTION[2009/14]
English:PHARMACEUTICAL COMPOSITION FOR TREATING OR PREVENTING HCV INFECTION[2009/14]
French:COMPOSITION PHARMACEUTIQUE DESTINÉE AU TRAITEMENT OU À LA PRÉVENTION D'UNE INFECTION PAR LE VHC[2009/14]
Entry into regional phase05.12.2008Translation filed 
05.12.2008National basic fee paid 
05.12.2008Search fee paid 
05.12.2008Designation fee(s) paid 
05.12.2008Examination fee paid 
Examination procedure05.12.2008Examination requested  [2009/14]
11.02.2009Amendment by applicant (claims and/or description)
15.05.2012Application deemed to be withdrawn, date of legal effect  [2012/46]
22.06.2012Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2012/46]
Fees paidRenewal fee
05.12.2008Renewal fee patent year 03
26.03.2010Renewal fee patent year 04
24.05.2011Renewal fee patent year 05
Penalty fee
Additional fee for renewal fee
31.05.201206   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[X]WO0037097  (SCHERING CORP [US]) [X] 6 * abstract *;
 [X]WO2004078127  (INTERMUNE INC [US], et al) [X] 6 * abstract *;
 [X]WO2005062949  (INTERMUNE INC [US], et al) [X] 6 * abstract *;
 [X]  - SAKAMOTO H ET AL, "Host sphingolipid biosynthesis as a target for hepatitis C virus therapy", NATURE CHEMICAL BIOLOGY, NATURE PUBLISHING GROUP, NEW YORK, NY, US, (20051101), vol. 1, no. 6, doi:10.1038/NCHEMBIO742, ISSN 1552-4450, pages 333 - 337, XP003010463 [X] 5 * abstract *

DOI:   http://dx.doi.org/10.1038/nchembio742
 [XP]  - UMEHARA ET AL, "Serine palmitoyltransferase inhibitor suppresses HCV replication in a mouse model", BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, ACADEMIC PRESS INC. ORLANDO, FL, US, (20060721), vol. 346, no. 1, doi:10.1016/J.BBRC.2006.05.085, ISSN 0006-291X, pages 67 - 73, XP005485804 [XP] 1-19 * Discussion *

DOI:   http://dx.doi.org/10.1016/j.bbrc.2006.05.085
International search[Y]WO2006016657  (CHUGAI PHARMACEUTICAL CO LTD [JP], et al);
 [Y]WO2005005372  (CHUGAI PHARMACEUTICAL CO LTD [JP], et al);
 [Y]JP2004511513  ;
 [Y]JP2005533108  ;
 [Y]JP2005533824
by applicantWO2006016657
 WO2004071503
 WO2005005372
 JP2980569B
    - GLUE, P. ET AL., HEPATOLOGY, (2000), vol. 32, pages 647 - 653
    - REDDY, K.R. ET AL., HEPATOLOGY, (2001), vol. 33, pages 433 - 438
    - ROSENBERG, S., J MOL BIOL, (2001), vol. 313, pages 451 - 464
    - AIZAKI, H. ET AL., VIROLOGY, (2004), vol. 324, pages 450 - 461
    - GAO, L. ET AL., J VIROL, (2004), vol. 78, pages 3480 - 3488
    - FUJITA, T. ET AL., J ANTIBIOT (TOKYO, (1994), vol. 47, pages 208 - 215
    - MIYAKE, Y ET AL., BIOCHEM BIOPHYS RES COMMUN, (1995), vol. 211, pages 396 - 403
    - SIMONS, K.; IKONEN, E., NATURE, (1997), vol. 387, pages 569 - 572
    - SAKAMOTO, H. ET AL., NAT CHEM BIOL, (2005), vol. 1, pages 333 - 337
    - NAT CHEM BIOL., (200511), vol. 1, no. 6, pages 333 - 7
    - NAT CHEM BIOL., (200511), vol. L, no. 6, pages 333 - 7
    - J. M. BUZAYAN, NATURE, (1986), vol. 323, page 349
    - K. TAIRA ET AL., PROTEIN ENG., (1990), vol. 3, page 733
    - A. M. DZAIANOTT; J. J. BUJARSKI, PROC. NATL. ACAD. SCI. USA, (1989), vol. 86, page 4823
    - C. A. GROSSHANDS; R. T. CECH, NUCLEIC ACIDS RES., (1991), vol. 19, page 3875
    - K. TAIRA ET AL., NUCLEIC ACID RES., (1991), vol. 19, page 5125
    - N. YUYAMA ET AL., BIOCHEM. BIOPHYS. RES. COMMUN., (1992), vol. 186, page 1271
    - KARLIN; ALTSCHUL, PROC. NATL. ACAD. SCI. USA., (1990), vol. 87, pages 2264 - 2268
    - PROC. NATL. ACAD. SCI. USA, (1993), vol. 90, pages 5873 - 5877
    - ALTSCHUL ET AL., J. MOL. BIOL., (1990), vol. 215, pages 403 - 410
    - TAKEUCHI, T. ET AL., GASTROENTEROLOGY, (1999), vol. 116, pages 636 - 642
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.